MAPT and Alzheimer disease: “Since a progressive shift of brain tau from soluble to insoluble pools plays a mechanistic role in the onset and/or progression of AD (Geerts et al., 2013)”, YZT mediated decrease in insoluble phospho tau clearly demonstrates its ability to delay the onset of tau pathogenesis in AD.